Skip to main content
IntegraGen logo

IntegraGen — Investor Relations & Filings

Ticker · ALINT ISIN · FR0010908723 LEI · 969500CQD8K0BUIGDH55 PA Professional, scientific and technical activities
Open in API
Filings indexed 160 across all filing types
Latest filing 2018-03-01 Share Issue/Capital Cha…
Country FR France
Listing PA ALINT

About IntegraGen

https://integragen.com/

IntegraGen, an OncoDNA company, specializes in translating molecular research into clinical practice, with a primary focus on cancer genomics and rare genetic diseases. The company provides comprehensive genomic services, including Next-Generation Sequencing (NGS) and advanced bioinformatics analysis, to academic researchers, biopharmaceutical companies, and clinical research organizations. Operating from a CLIA/CAP-certified laboratory, IntegraGen is a key genomics partner for oncology clinical trials. Its core mission involves identifying novel genetic biomarkers to develop and commercialize molecular diagnostic tests, delivering interpretable genomic data to advance both research and patient care.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relative to the Total Number of Voting Rights and Shares Comprising the Share Capital). It explicitly references Article 223-16 of the AMF General Regulation and provides a table comparing the total number of shares and voting rights as of February 28, 2018, and January 31, 2018. This content directly relates to tracking changes in share capital and voting rights, which aligns best with the 'Major Shareholding Notification' (MRQ) definition, as it reports on the composition of the capital, often required when significant changes occur or on a regular basis for transparency. Although it is a monthly report, it is not a comprehensive financial report (IR or 10-K) or a dividend notice (DIV). It is a specific regulatory disclosure about the capital structure.
2018-03-01 French
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 86% confidence The document is a press release dated February 14, 2018, announcing a global distribution agreement between IntegraGen and Twist Bioscience for IntegraGen's genomic analysis tools (SIRIUS and MERCURY). This announcement details a strategic business partnership and expansion of services, which falls under corporate actions or significant business updates. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). Since it describes a significant business development (a major distribution agreement) that impacts the company's operations and market reach, it is best classified as a general announcement that doesn't fit the highly specific financial report codes. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for significant, non-standard corporate announcements, although 'M&A Activity' (TAR) is for M&A, not distribution deals. However, looking closely at the definitions, none perfectly capture a 'Strategic Partnership Announcement'. RNS is the general regulatory/miscellaneous filing category. Given the context of a press release announcing a major commercial agreement, RNS serves as the best fit among the provided codes for a significant, non-financial report announcement.
2018-02-14 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the AMF General Regulation and provides a table comparing the total number of shares and voting rights as of January 31, 2018, compared to December 31, 2017. This content directly relates to the official disclosure of changes in the total number of shares and voting rights, which is a specific regulatory disclosure often related to capital structure or shareholder rights reporting. Among the provided codes, 'SHA' (Share Issue/Capital Change) or 'DVA' (Declaration of Voting Results & Voting Rights Announcements) are the closest fits. Since this is a monthly update on the total number of voting rights and shares, it is most accurately classified as a notification regarding the capital structure, aligning best with 'SHA' (Share Issue/Capital Change) or potentially 'DVA' if the focus is strictly on voting rights disclosure, though 'SHA' covers the underlying share count change aspect. Given the explicit focus on the total number of shares and voting rights, and the monthly nature, it is a mandatory disclosure related to the capital base. However, looking closely at the definitions, 'DVA' is for 'Official results from shareholder votes at any general meeting'. This document is not about voting results from a meeting, but the total voting power available. 'SHA' covers 'Announcement regarding new share issues, stock splits, or other capital changes.' This monthly disclosure is a mandatory update on the capital base. In many European contexts, these monthly voting rights disclosures are often grouped with capital structure updates. Given the options, 'SHA' is a strong candidate, but 'RNS' (Regulatory Filings) is a safe fallback for mandatory, non-core financial reports. Let's re-evaluate the options based on the content: It is a mandatory disclosure of the total share count and voting rights. This is a specific type of capital structure update. 'SHA' seems the most appropriate specific category for updates on the total number of shares/capital base. If a more specific code existed for 'Total Voting Rights Disclosure', that would be ideal, but 'SHA' covers the underlying share count. I will classify it as 'SHA' due to the explicit reporting of the total number of shares and voting rights, which reflects the current capital structure.
2018-02-01 French
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated January 25, 2018, announcing a partnership between IntegraGen and Twist Bioscience regarding the use of Twist Bioscience's Core Exome Kit. This type of announcement, detailing a new commercial agreement, technology integration, or strategic partnership, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or corporate governance filings (like DEF 14A, DVA). It is a general corporate announcement. Since it is not a report itself, nor a specific filing like a Director's Dealing or Dividend Notice, the most appropriate general category for a significant corporate development announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which often serves as a catch-all for press releases detailing business updates.
2018-01-25 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a 'PRESS RELEASE' announcing the launch of two new Big Data SaaS tools, SIRIUS™ and MERCURY™, by IntegraGen. It details the features, intended users (clinicians, pathologists, researchers), and commercial launch dates. This type of announcement, focusing on a new product or service launch rather than financial results (ER), management changes (MANG), or capital structure (CAP), does not fit neatly into the primary financial filing categories (10-K, IR, DIV, etc.). Since it is a general corporate announcement that doesn't fit a more specific category like Earnings Release (ER) or Management Change (MANG), it falls best under the general regulatory/corporate announcement category, which is Regulatory Filings (RNS). The document length (4770 chars) is substantial enough that it is the primary content, not just a brief announcement of another report.
2018-01-18 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is explicitly titled "COMMUNIQUÉ DE PRESSE - DIFFUSION IMMÉDIATE" (Press Release - Immediate Release) and announces the launch of two new Big Data solutions (SIRIUS™ and MERCURY™) by IntegraGen on January 18, 2018. This format, focusing on a specific corporate event (product launch) and distributed immediately, aligns perfectly with an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a comprehensive financial report (10-K, IR), an audit report (AR), or a management discussion (MDA), and it is a specific announcement rather than a general notice about a report publication (RPA), the most appropriate classification is Earnings Release (ER) if it were tied to a reporting period, or Regulatory Filing (RNS) as a general announcement. Given the context of a product launch announcement, which often accompanies or precedes financial reporting, and the lack of specific quarterly/annual financial summary typical of an ER, RNS serves as the best general regulatory announcement category. However, in many databases, significant corporate news like major product launches are often categorized under ER if they are the primary communication for that day, or RNS if they are purely operational/product news. Since this is a press release announcing a business development, RNS (Regulatory Filings / General Regulatory Announcements) is the most accurate fallback for non-standard financial disclosures.
2018-01-18 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.